Afficher la couverture 'Behavioural and sleep issues after initiation of elexacaftor–tezacaftor–ivacaftor in preschool-age children with cystic fibrosis | Sermet-Gaudelus, I' en grand format
/5

0 avis

Consulter en ligne

Suggestions

Du même auteur

Impact of elexacaftor/tezacaftor/ivacaftor on glucose tolerance in adolescents with cystic fibrosis

Archive ouverte | Galderisi, Alfonso | CCSD

International audience. Abstract Background Highly effective CFTR modulators, such as elexacaftor/tezacaftor/ivacaftor (ETI), herald a new era in therapeutic strategy of cystic fibrosis (CF). ETI impact on glucose t...

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Archive ouverte | Burgel, Pierre-Régis | CCSD

International audience. Background Elexacaftor-tezacaftor-ivacaftor has been approved in Europe for people with cystic fibrosis with at least one F508del CFTR variant. Additionally, it is approved by the US Food and...

The expanded French compassionate programme for elexacaftor–tezacaftor–ivacaftor use in people with cystic fibrosis without a F508del CFTR variant: a real-world study

Archive ouverte | Burgel, Pierre-Régis | CCSD

International audience

Chargement des enrichissements...